John Johnson, Director of Axogen AXGN, has filed 0 purchases and 9 sales on the open market. Over the past 12 months that comes to a net sale of $2.9M. The latest trade was on 06/24.

JJ

JJ

John Johnson

Director

Company

Axogen AXGN

First filing

23/05/16

Trades

48 trades

Buys / sales

0 / 9

12-month net buying

−$2.9M

Last trade

06/24

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Xeris Biopharma HoldingsXERS	Open-market sale10b5-1 plan	06/04	06/05	15,000 sh	$6.09	$91,350	−2.1%
AxogenAXGN	Open-market sale	05/07	05/08	11,050 sh	$43.26	$478,023	−100.0%
Xeris Biopharma HoldingsXERS	Open-market sale	25/12/19	25/12/19	135,400 sh	$7.22	$977,588	−16.2%
AxogenAXGN	Open-market sale	25/12/08–25/12/09	25/12/10	45,379 sh4 trades	$30.64avg.	$1,390,313.82	−100.0%
Xeris Biopharma HoldingsXERS	Open-market sale	25/08/13	25/08/15	107,500 sh	$7.32	$786,900	−11.4%
AxogenAXGN	Open-market sale	25/06/09	25/06/11	4,073 sh	$10.61	$43,214.53	−14.0%